The Journal of Organic Chemistry
Article
× CH), 131.2 (CH), 132.8 (CH), 133.9 (d, JCF = 3.4 Hz, Cq), 142.2
(Cq), 162.3 (d, JCF = 247.3 Hz, Cq); 19F-NMR (339 MHz, CDCl3) δ
−117.3; MS (EI) m/z 327 (10), 268 (13), 267 (81) [81Br-M+], 266
(23), 265 (91) [79Br-M+], 264 (12), 252 (43), 250 (23), 235 (27), 233
(16), 219 (16), 186 (27), 185 (100), 184 (23), 167 (19), 166 (16),
158 (11), 157 (21), 139 (11), 133 (13), 93 (22), 92 (37), 85 (19), 83
(29); HRMS (EI) calcd for C12H9BrFN [M+] 264.9902, found
264.9903.
5-Bromo-4′-chlorobiphenyl-2-amine (22). According to GP 3,
the title compound was prepared from 4-chlorophenylhydrazine
hydrochloride (1( × HCl)) (179 mg, 1.00 mmol), 4-bromoaniline
(12) (3.44 g, 20.0 mmol), NaHCO3 (420 mg, 5.00 mmol), and MnO2
(435 mg, 5.00 mmol). Purification by column chromatography
(hexane/EtOAc = 10:1) gave 22 as a black oil (152 mg, 0.54 mmol,
54%). The analytical data obtained are in agreement with those
reported in ref 11c.
5-Bromo-2′-chlorobiphenyl-2-amine (23). According to GP 2,
the title compound was prepared from 2-chlorophenylhydrazine (6)
(143 mg, 1.00 mmol), 4-bromoaniline (12) (3.44 g, 20.0 mmol) and
MnO2 (435 mg, 5.00 mmol). Purification by column chromatography
(hexane/EtOAc = 10:1) gave 23 (162 mg, 0.57 mmol, 57%): dark
brown oil; Rf = 0.4 (hexane/EtOAc = 4:1) (UV); 1H NMR (600 MHz,
CDCl3) δ 3.77 (bs, 2 H), 6.69 (d, J = 8.6 Hz, 1 H), 7.18 (d, J = 2.3 Hz,
1 H), 7.27−7.36 (m, 4 H), 7.47−7.52 (m, 1 H); 13C NMR (91 MHz,
CDCl3) δ 129.7 (Cq), 136.8 (CH), 146.8 (Cq), 146.9 (CH), 149.1
(CH), 149.5 (CH), 151.3 (CH), 151.3 (CH), 152.4 (CH), 153.3 (Cq),
156.0 (Cq), 162.0 (Cq); MS (EI) m/z (%): 285 (23), 284 (12) [37Cl-
M+], 283 (90), 282 (10) [35Cl-M+], 281 (73), 248 (73), 247 (40), 246
(69), 245 (34), 168 (37), 167 (100), 166 (71), 164 (10), 140 (28),
139 (52), 138 (10), 101 (13), 83 (40), 83 (23), 82 (20), 69 (21), 63
(11); HRMS (EI) calcd for C12H10BrClN [M+] 280.9607, found
280.9607.
4′-Chloro-5-cyanobiphenyl-2-amine (24). According to GP 3,
the title compound was prepared from 4-chlorophenylhydrazine
hydrochloride (1( × HCl)) (179 mg, 1.00 mmol), 4-amino-
benzonitrile (13) (1.18 g, 20.0 mmol), NaHCO3 (420 mg, 5.00
mmol), and MnO2 (435 mg, 5.00 mmol). Purification by column
chromatography (hexane/EtOAc = 10:1) gave 24 as reddish crystalline
solid (91.2 mg, 0.35 mmol, 35%), mp 154−157 °C. The analytical data
obtained are in agreement with those reported in ref 11c.
8.6 Hz, 2 H); 13C NMR (151 MHz, CDCl3) δ 109.9 (dd, JCF = 4.3 Hz,
JCF = 16.9 Hz, 2 × CH), 115.5 (2 × CH), 127.7 (2 × CH), 128.4 (Cq),
137.3 (dt, JCF = 4.4 Hz, JCF = 8.0 Hz, Cq), 138.4 (td, JCF = 15.5 Hz, JCF
= 250.0 Hz, Cq), 146.5 (Cq), 151.3 (ddd, JCF = 4.4 Hz, JCF = 9.9 Hz,
JCF = 248.5 Hz, 2 × Cq); 19F NMR (339 MHz, CDCl3) δ −138.0,
−167.7; MS (EI) m/z 272 (14), 270 (47), 268 (26), 235 (27), 233
(15) [M+], 224 (13), 223 (100), 219 (10), 195 (10), 85 (44), 83 (62);
HRMS (EI) calcd for C12H8F3N [M+] 223.0609, found 223.0610.
4′-Chlorobiphenyl-2-amine (27). According to GP 2, the title
compound was prepared from 4-chlorophenylhydrazine (1) (143 mg,
1.00 mmol), aniline (15) (1.82 mL, 20.0 mmol), and MnO2 (435 mg,
5.00 mmol). Purification of the regioisomers by column chromatog-
raphy (hexane/EtOAc = 10:1 → 4:1) gave 27 as a dark brown
amorphous solid (83.9 mg, 0.41 mmol, 41%)33 (mp 37−38 °C) and
4′-chlorobiphenyl-4-amine (27′) as a black oil (26.2 mg, 0.13 mmol,
13%).11c The analytical data obtained for 27 and 27′ are in agreement
with those reported in refs 11c and 33.
2′-Chlorobiphenyl-2-amine (28). According to GP 2, the title
compound was prepared from 2-chlorophenylhydrazine (6) (143 mg,
1.00 mmol), aniline (15) (1.82 mL, 20.0 mmol), and MnO2 (435 mg,
5.00 mmol). Purification of the regioisomers by column chromatog-
raphy (hexane/EtOAc = 10:1 → 4:1) gave 2′-chlorobiphenyl-4-amine
(28′) as a black oil (41.8 mg, 0.21 mmol, 21%) and 28 as a black
amorphous solid (98.7 mg, 0.49 mmol, 49%) (mp 52−53 °C). The
analytical data obtained for 28 are in agreement with those reported in
ref 31e. 2′-Chlorobiphenyl-4-amine (28′): Rf = 0.3 (hexane/EtOAc =
4:1) (UV); 1H NMR (600 MHz, CDCl3) δ 3.73 (bs, 2 H), 6.73 (d, J =
8.6 Hz, 2 H), 7.21 (ddd, J = 1.8 Hz, J = 7.3 Hz, J = 7.9 Hz, 1 H), 7.25−
7.28 (m, 3 H), 7.31 (dd, J = 1.8 Hz, J = 7.4 Hz, 1H), 7.43 (dd, J = 1.1
Hz, J = 7.9 Hz, 1H); 13C NMR (91 MHz, CDCl3) δ 114.5 (2 × CH),
126.7 (CH), 127.8 (CH), 129.6 (Cq), 129.9 (CH), 130.4 (2 × CH),
131.3 (CH), 132.5 (Cq), 140.5 (Cq), 145.9 (Cq); MS (EI) m/z 205
(32) [37Cl-M+], 204 (13), 203 (100) [35Cl-M+], 168 (11), 167 (21),
139 (8), 115 (6), 101 (6), 83 (10), 44 (25); HRMS (EI) calcd for
C12H10ClN [M+] 203.0502, found 203.0502.
2-(4-Chlorophenyl)furan (29). According to GP 3, the title
compound was prepared from 4-chlorophenylhydrazine hydrochloride
(1( × HCl)) (179 mg, 1.00 mmol), furan (2.90 mL, 40.0 mmol),
NaHCO3 (420 mg, 5.00 mmol), and MnO2 (435 mg, 5.00 mmol).
Purification by column chromatography (hexane/EtOAc = 19:1) gave
29 as an orange crystalline solid (110 mg, 0.62 mmol, 62%) (mp 80−
85 °C). The analytical data obtained are in agreement with those
reported in ref 22.
4′-Chlorobiphenyl-2-ol (30). Method a (Scheme 1): According
to GP 3, the title compounds were prepared from 4-chlorophenylhy-
drazine hydrochloride (1( × HCl)) (179 mg, 1.00 mmol), phenol
(1.88 g, 20.0 mmol), NaHCO3 (420 mg, 5.00 mmol), and MnO2 (435
mg, 5.00 mmol). Purification by column chromatography (hexane/
EtOAc = 10:1) gave 30 (60.2 mg, 0.29 mmol, 29%)34 and 30′ (19.0
mg, 0.09 mmol, 9%).35 The analytical data obtained are in agreement
with those reported in refs 34 and 35.
4′-Chloro-5-methoxybiphenyl-2-amine (25). According to GP
2, the title compound was prepared from 4-chlorophenylhydrazine (1)
(143 mg, 1.00 mmol), p-anisidine (14) (2.46 g, 20.0 mmol), and
MnO2 (435 mg, 5.00 mmol). Purification by column chromatography
(hexane/EtOAc = 10:1) gave 25 as a brown oil (91.2 mg, 0.39 mmol,
39%). The analytical data obtained are in agreement with those
reported in ref 11a.
3′,4′,5′-Trifluorobiphenyl-2-amine (26). According to GP 2, the
title compound was prepared from 3,4,5-trifluorophenylhydrazine (10)
(146 mg, 0.90 mmol), aniline (15) (1.64 mL, 18.0 mmol) and MnO2
(392 mg, 4.50 mmol). Purification of the regioisomers by column
chromatography (hexane/EtOAc = 10:1 → 4:1) gave 26 (118 mg,
0.53 mmol, 59%) and 3′,4′,5′-trifluorobiphenyl-4-amine (26′) (32.5
mg, 0.15 mmol, 16%). 3′,4′,5′-Trifluorobiphenyl-2-amine (26): brown
crystalline solid; mp 69−72 °C; Rf = 0.6 (hexane/EtOAc = 4:1) (UV);
1H NMR (360 MHz, CDCl3) δ 3.79 (bs, 2 H), 6.77 (dd, J = 0.8 Hz, J
= 8.0 Hz, 1 H), 6.83 (dt, J = 1.0 Hz, J = 7.5 Hz, 1 H), 7.06 (dd, J = 1.6
Hz, J = 7.6 Hz, 1 H), 7.07−7.13 (m, 2 H), 7.19 (ddd, J = 1.6 Hz, J =
7.4 Hz, J = 8.0 Hz, 1 H); 13C NMR (151 MHz, CDCl3) δ 113.2 (dd,
JCF = 4.5 Hz, JCF = 16.4 Hz, 2 × CH), 116.0 (CH), 118.9 (CH), 124.4
(d, JCF = 1.0 Hz, Cq), 129.4 (CH), 130.1 (CH), 135.5 (dt, JCF = 4.9
Hz, JCF = 7.9 Hz, Cq), 138.9 (td, JCF = 15.3 Hz, JCF = 251.6 Hz, Cq),
143.2 (Cq), 151.3 (ddd, JCF = 4.4 Hz, JCF = 9.9 Hz, JCF = 250.5 Hz, 2 ×
Cq); 19F-NMR (339 MHz, CDCl3) δ −137.1, −165.4; MS (EI) m/z
268 (23), 266 (13), 224 (15), 223 (100) [M+], 222 (26), 221 (12),
204 (12), 203 (18), 85 (21), 83 (30); HRMS (EI) calcd for C12H8F3N
[M+] 223.0609, found 223.0609. 3′,4′,5′-Trifluorobiphenyl-4-amine
(26′): brown crystalline solid; mp 75−80 °C; Rf = 0.2 (hexane/EtOAc
= 4:1) (UV); 1H NMR (360 MHz, CDCl3) δ 3.82 (bs, 2 H), 6.74 (d, J
= 8.7 Hz, 2 H), 7.11 (dd, J = 6.5 Hz, JHF = 9.3 Hz, 2 H), 7.31 (d, J =
Method b (Scheme 1): To a stirred suspension of phenol (1.88 g,
20.0 mmol), aqueous NaOH (8 M, 3.13 mL, 25.0 mmol), and MnO2
(435 mg, 5.00 mmol) in acetonitrile (5 mL) at rt was added 4-
chlorophenylhydrazine hydrochloride (1( × HCl)) (179 mg, 1.00
mmol) in portions over a period of 10 min. After completion of the
reaction, as monitored by TLC, the reaction mixture was filtered over
Celite. The filter cake was further washed with ethyl acetate. The
organic layer was washed with water (30 mL) and saturated aqueous
NaCl and dried over Na2SO4. The solvent was removed under reduced
pressure. The remaining substrate was removed by Kugelrohr
distillation and purification by column chromatography (hexane/
EtOAc = 10:1) gave 30 as a brown amorphous solid (81.9 mg, 0.40
mmol, 40%)34 (mp 45−47 °C) and 30′ as a brown amorphous solid
(34.9 mg, 0.17 mmol, 17%)35 (mp 130−135 °C). The analytical data
obtained are in agreement with those reported in refs 34 and 35.
4′-Chloro-2-methoxybiphenyl (31). According to GP 3, the title
compounds were prepared from 4-chlorophenylhydrazine hydro-
chloride (1( × HCl)) (179 mg, 1.00 mmol), anisole (2.18 mL, 20.0
mmol), NaHCO3 (420 mg, 5.00 mmol), and MnO2 (435 mg, 5.00
10704
dx.doi.org/10.1021/jo301980j | J. Org. Chem. 2012, 77, 10699−10706